We use cookies to improve the technical capabilities of the service and to analyze user activity. You can learn more about cookies in our Privacy Policy (personal data processing). By clicking “Accept”, you agree to the conditions for the processing of cookies and other analytics information.
Accept
GemoVis
HEMOSTATIC GEL
Sterile, single‑use hemostatic gel for highly effective and targeted control of bleeding of various intensity.
Short time to achieve complete hemostasis—less than 60 seconds. By stopping massive bleeding more than three times faster, it reduces blood loss volume by more than three times.
Effective for preventing infections, which are common complications of injuries sustained in field conditions, due to its antiseptic activity.
Convenient gel form completely fills the wound area, helping to stop bleeding from wounds with complex configuration.
SPEED OF ACTION
ANTISEPTIC PROPERTIES
FORM OF RELEASE

«Every drop matters»

Bleeding is one of the most serious complications in various injuries, wounds, traumas, and surgical interventions.

High‑quality hemostasis control plays a crucial role in reducing overall blood loss and preventing recurrent bleeding episodes.

The problem of temporary control of external hemorrhage is one of the most important not only in military medicine but also in civil emergency medicine.

The use of hemostatic gel GEMOVIS allows stabilization and preparation of injured patients for evacuation, avoiding massive blood loss.
Gemovis gel – corrugated bottle 85 ml with an applicator.
The use of local hemostatic agent GEMOVIS in field conditions during combat operations, including self‑aid, allows stabilization and preparation of severely injured personnel for evacuation and helps avoid massive blood loss.

GEMOVIS local hemostatic agent meets the requirements set for agents of this group both in tactical battlefield medicine and in military field surgery. According to field test results, GEMOVIS has proved to be a highly effective means of stopping massive bleeding caused by gunshot and, especially, fragment wounds resulting from mine‑explosive trauma.

Effective hemostasis is achieved in more than 95% of cases within a time frame of less than 60 seconds. Prompt use of GEMOVIS in first‑aid practice contributes to saving the lives of military personnel during combat operations by reducing blood loss in serious battlefield injuries.


HEMOSTATIC GEL
GemoVis